Expanding a program that allows profits to grow without transparency while also delivering minimal benefit to patients at the point-of-sale risks worsening those challenges rather than solving them. #drug #oped
Critics point to financial data suggesting 340B-participating hospitals in Illinois report significantly higher average patient revenues than non-participating hospitals. #drug #proposals
#critics